Selected Grants
COG AALL1732 JAZZ
Clinical TrialPrincipal Investigator · Awarded by Public Health Institute · 2024 - 2030A Phase 1/2 Trial of CBL0137 (NSC# 825802, IND# 155843
Clinical TrialPrincipal Investigator · Awarded by Public Health Institute · 2025 - 2030A Multi-Institution Study of TGFss; imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination with Gemcitabine and Docetaxel in Patients with Relapsed or Refractory Pediatric Bone and Soft Tissue Sarcomas
Clinical TrialPrincipal Investigator · Awarded by H. Lee Moffitt Cancer Center & Research Institute · 2024 - 2028AALL1732
Clinical TrialPrincipal Investigator · Awarded by Public Health Institute · 2025 - 2028Molecular Analysis for Therapy Choice Phase 2 of Palbociclib in patients with Tumors
Clinical TrialPrincipal Investigator · Awarded by Public Health Institute · 2022 - 2027BCC022: Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
ResearchPrincipal Investigator · Awarded by Pennsylvania State University · 2025 - 2026Expanding Clinical Trial Access for Pediatric and Young Adult Oncology Patients
ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2025 - 2026SWOG trial S1826
ResearchPrincipal Investigator · Awarded by Children's Oncology Group Foundation · 2025 - 2026MS Clinical Trial: DUOC
ResearchCo Investigator · Awarded by The Marcus Foundation · 2020 - 2025AR66913: PEPN1924 Leidos Site Correlative Services
ResearchPrincipal Investigator · Awarded by Public Health Institute · 2021 - 2025A Phase 1 study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3b) inhibitor
Clinical TrialPrincipal Investigator · Awarded by Actuate Therapeutics · 2021 - 2025An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults with Select Solid Tumors, Lymphoma, and Malignant Brain Tumors (CLOVER-2)
Clinical TrialPrincipal Investigator · Awarded by Cellectar Biosciences, Inc. · 2021 - 2024AR67988: Leidos AOST2032 Y1 PCR
ResearchPrincipal Investigator · Awarded by Public Health Institute · 2022 - 2024High Fidelity Diffusion MRI for Children with Cerebral Palsy in Stem Cell Therapy
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2023Marcus Foundation Phase II MSC ASD
ResearchCo Investigator · Awarded by The Marcus Foundation · 2019 - 2022A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2020 - 2022External Relationships
- CryoCell International
- Sino Cell Technologies - Changed name to SuperCell
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.